NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sequence Bio

Sequence Bio

Private
St. John'sHealthcare & Life Scienceshttps://www.sequencebio.com/

Last Round

VC Round

May 20, 2021

Est. Valuation

$2.14M

Total Funding Raised

$4.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sequence Bio is a biotechnology company that leverages the unique genetics of the Newfoundland and Labrador founder population to discover drug targets and develop medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

human genomicsdrug discoveryprecision medicinegenomic databasebiotech researchbiomarker discoverytherapeutic targetsclinical datagenomic sequencingdata as a serviceDaaSgenomic cohortpopulation genomicsbiopharma R&Dgenomic medicinebiobank

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sequence Bio Comparables

Compare Sequence Bio with similar companies based on industry and business-model similarity.

Sequence Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Population Bio, Inc.
80%
HiberCell
77%
Genomics
76%

Sequence Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 20, 2021
AcceleratorAug 23, 2019
SeedAug 3, 2016
SeedOct 20, 2015

Key People

Founding team and executive leadership

Lynn Healey

Chief Executive Officer At Sequence Bio, Chief Operating And Financial Officer

Executive Team

Sequence Bio Investors

Notable investors and investment history

Sequence Bio investors
InvestorRounds
Killick CapitalSeed
Y CombinatorAccelerator
Pelorus Venture CapitalSeed
Klister Credit Corp.Seed, VC Round
Columbus CapitalVC Round
DCVC (Data Collective)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors increased 42% MoM.

  • Aug 3, 2016

    $3M round led by DCVC (Data Collective)

Sequence Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sequence Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sequence Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSt. John's
Employee Range19
Year Founded2013
Last FundingMay 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.